Lexaria Bioscience, Improving Absorption and Potency of Medical Cannabinoids


Lexaria Bioscience’s patented technology is set to improve absorption time and potency of medical products including vitamins and pain relievers.

Lexaria is focused on generating revenue through out-licensing its technology internationally.

Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also improving taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery.

For more information on Lexaria Bioscience (LXX:CSE) fill out the form below.

Request Investor Kit